Loading…

Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia

Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an importan...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology 2023-09, Vol.14, p.1197970-1197970
Main Authors: Cai, Yulan, Luo, Yanhong, Dai, Ninan, Yang, Yan, He, Ying, Chen, Huajun, Zhao, Manlu, Fu, Xiaoyun, Chen, Tao, Xing, Zhouxiong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983
cites cdi_FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983
container_end_page 1197970
container_issue
container_start_page 1197970
container_title Frontiers in microbiology
container_volume 14
creator Cai, Yulan
Luo, Yanhong
Dai, Ninan
Yang, Yan
He, Ying
Chen, Huajun
Zhao, Manlu
Fu, Xiaoyun
Chen, Tao
Xing, Zhouxiong
description Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an important role in host metabolism and immunity. Nevertheless, the effects of hyperoxia on gut microbiome and metabolome remain unclear, and metagenomic and metabolomics analysis were performed in this mouse study. C57BL/6 mice were randomly divided into a control (CON) group exposed to room air with fractional inspired oxygen (FiO ) of 21% and a hyperoxia (OXY) group exposed to FiO of 80% for 7 days, respectively. Fecal pellets were collected on day 7 and subjected to metagenomic sequencing. Another experiment with the same design was performed to explore the impact of hyperoxia on gut and serum metabolome. Fecal pellets and blood were collected and high-performance liquid chromatography with mass spectrometric analysis was carried out. At the phylum level, hyperoxia increased the ratio of ( = 0.049). At the species level, hyperoxia reduced the abundance of ( = 0.007), ( = 0.010), and ( = 0.011) . Linear discriminant analysis effect size (LEfSe) revealed that and , both belonging to , were the marker microbes of the CON group, while was the marker microbes of the OXY group. Metagenomic analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Carbohydrate-Active enZYmes (CAZy) revealed that hyperoxia provoked disturbances in carbohydrate and lipid metabolism. Fecal metabolomics analysis showed hyperoxia reduced 11-dehydro Thromboxane B2-d4 biosynthesis ( = 1.10 × 10 ). Hyperoxia blunted fecal linoleic acid metabolism ( = 0.008) and alpha-linolenic acid metabolism ( = 0.014). We showed that 1-docosanoyl-glycer-3-phosphate ( = 1.58 × 10 ) was the most significant differential serum metabolite inhibited by hyperoxia. In addition, hyperoxia suppressed serum hypoxia-inducible factor-1 (HIF-1, = 0.007) and glucagon signaling pathways ( = 0.007). Hyperoxia leads to gut dysbiosis by eliminating beneficial and oxygen strictly intolerant with genomic dysfunction of carbohydrate and lipid metabolism. In addition, hyperoxia suppresses unsaturated fatty acid metabolism in the gut and inhibits the HIF-1 and glucagon signaling pathways in the serum.
doi_str_mv 10.3389/fmicb.2023.1197970
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c756ac3f67ff4434b416254654654bcf</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c756ac3f67ff4434b416254654654bcf</doaj_id><sourcerecordid>2878017369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983</originalsourceid><addsrcrecordid>eNpVkU1PHSEUhklTU436B1w0s-zmXoHDwLBqGtPbmpi4UeOOAANXzMxwCzON8-_lfmiUEOC8nPNwyIvQBcFLgEZe-j5Ys6SYwpIQKaTAX9AJ4ZwtANPHrx_Ox-g852dcBsO0rN_QMYiGYQH4BD2spsGOIQ66q3o36rUbYiFXemh3sYndNs5F0N2cQ66ir9bTWLVzNiFuhTC0k3VtZebqad64FF-CPkNHXnfZnR_2U3S_-n139Xdxc_vn-urXzcIyLsdFQ7R12GtiMedS1t4wKqBmFMumBexBY1IzYoHX3kJjoPQva2La8jepZQOn6HrPbaN-VpsUep1mFXVQOyGmtdJpDLZzyoqaawueC-8ZA2YY4bRmfDeN9YX1c8_aTKZ3rXXDmHT3Cfr5ZghPah3_K4JrLhmFQvhxIKT4b3J5VH3I1nWdHlycsqKNaDARwGVJpftUm2LOyfn3dwhWW4PVzmC1NVgdDC5F3z92-F7yZie8AuJuorg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2878017369</pqid></control><display><type>article</type><title>Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia</title><source>Open Access: PubMed Central</source><creator>Cai, Yulan ; Luo, Yanhong ; Dai, Ninan ; Yang, Yan ; He, Ying ; Chen, Huajun ; Zhao, Manlu ; Fu, Xiaoyun ; Chen, Tao ; Xing, Zhouxiong</creator><creatorcontrib>Cai, Yulan ; Luo, Yanhong ; Dai, Ninan ; Yang, Yan ; He, Ying ; Chen, Huajun ; Zhao, Manlu ; Fu, Xiaoyun ; Chen, Tao ; Xing, Zhouxiong</creatorcontrib><description>Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an important role in host metabolism and immunity. Nevertheless, the effects of hyperoxia on gut microbiome and metabolome remain unclear, and metagenomic and metabolomics analysis were performed in this mouse study. C57BL/6 mice were randomly divided into a control (CON) group exposed to room air with fractional inspired oxygen (FiO ) of 21% and a hyperoxia (OXY) group exposed to FiO of 80% for 7 days, respectively. Fecal pellets were collected on day 7 and subjected to metagenomic sequencing. Another experiment with the same design was performed to explore the impact of hyperoxia on gut and serum metabolome. Fecal pellets and blood were collected and high-performance liquid chromatography with mass spectrometric analysis was carried out. At the phylum level, hyperoxia increased the ratio of ( = 0.049). At the species level, hyperoxia reduced the abundance of ( = 0.007), ( = 0.010), and ( = 0.011) . Linear discriminant analysis effect size (LEfSe) revealed that and , both belonging to , were the marker microbes of the CON group, while was the marker microbes of the OXY group. Metagenomic analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Carbohydrate-Active enZYmes (CAZy) revealed that hyperoxia provoked disturbances in carbohydrate and lipid metabolism. Fecal metabolomics analysis showed hyperoxia reduced 11-dehydro Thromboxane B2-d4 biosynthesis ( = 1.10 × 10 ). Hyperoxia blunted fecal linoleic acid metabolism ( = 0.008) and alpha-linolenic acid metabolism ( = 0.014). We showed that 1-docosanoyl-glycer-3-phosphate ( = 1.58 × 10 ) was the most significant differential serum metabolite inhibited by hyperoxia. In addition, hyperoxia suppressed serum hypoxia-inducible factor-1 (HIF-1, = 0.007) and glucagon signaling pathways ( = 0.007). Hyperoxia leads to gut dysbiosis by eliminating beneficial and oxygen strictly intolerant with genomic dysfunction of carbohydrate and lipid metabolism. In addition, hyperoxia suppresses unsaturated fatty acid metabolism in the gut and inhibits the HIF-1 and glucagon signaling pathways in the serum.</description><identifier>ISSN: 1664-302X</identifier><identifier>EISSN: 1664-302X</identifier><identifier>DOI: 10.3389/fmicb.2023.1197970</identifier><identifier>PMID: 37840730</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>gut dysbiosis ; gut metabolome ; gut microbiome ; hyperoxia ; metagenomic sequencing ; Microbiology ; serum metabolome</subject><ispartof>Frontiers in microbiology, 2023-09, Vol.14, p.1197970-1197970</ispartof><rights>Copyright © 2023 Cai, Luo, Dai, Yang, He, Chen, Zhao, Fu, Chen and Xing.</rights><rights>Copyright © 2023 Cai, Luo, Dai, Yang, He, Chen, Zhao, Fu, Chen and Xing. 2023 Cai, Luo, Dai, Yang, He, Chen, Zhao, Fu, Chen and Xing</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983</citedby><cites>FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569423/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569423/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27900,27901,53765,53767</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37840730$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cai, Yulan</creatorcontrib><creatorcontrib>Luo, Yanhong</creatorcontrib><creatorcontrib>Dai, Ninan</creatorcontrib><creatorcontrib>Yang, Yan</creatorcontrib><creatorcontrib>He, Ying</creatorcontrib><creatorcontrib>Chen, Huajun</creatorcontrib><creatorcontrib>Zhao, Manlu</creatorcontrib><creatorcontrib>Fu, Xiaoyun</creatorcontrib><creatorcontrib>Chen, Tao</creatorcontrib><creatorcontrib>Xing, Zhouxiong</creatorcontrib><title>Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia</title><title>Frontiers in microbiology</title><addtitle>Front Microbiol</addtitle><description>Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an important role in host metabolism and immunity. Nevertheless, the effects of hyperoxia on gut microbiome and metabolome remain unclear, and metagenomic and metabolomics analysis were performed in this mouse study. C57BL/6 mice were randomly divided into a control (CON) group exposed to room air with fractional inspired oxygen (FiO ) of 21% and a hyperoxia (OXY) group exposed to FiO of 80% for 7 days, respectively. Fecal pellets were collected on day 7 and subjected to metagenomic sequencing. Another experiment with the same design was performed to explore the impact of hyperoxia on gut and serum metabolome. Fecal pellets and blood were collected and high-performance liquid chromatography with mass spectrometric analysis was carried out. At the phylum level, hyperoxia increased the ratio of ( = 0.049). At the species level, hyperoxia reduced the abundance of ( = 0.007), ( = 0.010), and ( = 0.011) . Linear discriminant analysis effect size (LEfSe) revealed that and , both belonging to , were the marker microbes of the CON group, while was the marker microbes of the OXY group. Metagenomic analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Carbohydrate-Active enZYmes (CAZy) revealed that hyperoxia provoked disturbances in carbohydrate and lipid metabolism. Fecal metabolomics analysis showed hyperoxia reduced 11-dehydro Thromboxane B2-d4 biosynthesis ( = 1.10 × 10 ). Hyperoxia blunted fecal linoleic acid metabolism ( = 0.008) and alpha-linolenic acid metabolism ( = 0.014). We showed that 1-docosanoyl-glycer-3-phosphate ( = 1.58 × 10 ) was the most significant differential serum metabolite inhibited by hyperoxia. In addition, hyperoxia suppressed serum hypoxia-inducible factor-1 (HIF-1, = 0.007) and glucagon signaling pathways ( = 0.007). Hyperoxia leads to gut dysbiosis by eliminating beneficial and oxygen strictly intolerant with genomic dysfunction of carbohydrate and lipid metabolism. In addition, hyperoxia suppresses unsaturated fatty acid metabolism in the gut and inhibits the HIF-1 and glucagon signaling pathways in the serum.</description><subject>gut dysbiosis</subject><subject>gut metabolome</subject><subject>gut microbiome</subject><subject>hyperoxia</subject><subject>metagenomic sequencing</subject><subject>Microbiology</subject><subject>serum metabolome</subject><issn>1664-302X</issn><issn>1664-302X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1PHSEUhklTU436B1w0s-zmXoHDwLBqGtPbmpi4UeOOAANXzMxwCzON8-_lfmiUEOC8nPNwyIvQBcFLgEZe-j5Ys6SYwpIQKaTAX9AJ4ZwtANPHrx_Ox-g852dcBsO0rN_QMYiGYQH4BD2spsGOIQ66q3o36rUbYiFXemh3sYndNs5F0N2cQ66ir9bTWLVzNiFuhTC0k3VtZebqad64FF-CPkNHXnfZnR_2U3S_-n139Xdxc_vn-urXzcIyLsdFQ7R12GtiMedS1t4wKqBmFMumBexBY1IzYoHX3kJjoPQva2La8jepZQOn6HrPbaN-VpsUep1mFXVQOyGmtdJpDLZzyoqaawueC-8ZA2YY4bRmfDeN9YX1c8_aTKZ3rXXDmHT3Cfr5ZghPah3_K4JrLhmFQvhxIKT4b3J5VH3I1nWdHlycsqKNaDARwGVJpftUm2LOyfn3dwhWW4PVzmC1NVgdDC5F3z92-F7yZie8AuJuorg</recordid><startdate>20230928</startdate><enddate>20230928</enddate><creator>Cai, Yulan</creator><creator>Luo, Yanhong</creator><creator>Dai, Ninan</creator><creator>Yang, Yan</creator><creator>He, Ying</creator><creator>Chen, Huajun</creator><creator>Zhao, Manlu</creator><creator>Fu, Xiaoyun</creator><creator>Chen, Tao</creator><creator>Xing, Zhouxiong</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230928</creationdate><title>Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia</title><author>Cai, Yulan ; Luo, Yanhong ; Dai, Ninan ; Yang, Yan ; He, Ying ; Chen, Huajun ; Zhao, Manlu ; Fu, Xiaoyun ; Chen, Tao ; Xing, Zhouxiong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>gut dysbiosis</topic><topic>gut metabolome</topic><topic>gut microbiome</topic><topic>hyperoxia</topic><topic>metagenomic sequencing</topic><topic>Microbiology</topic><topic>serum metabolome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cai, Yulan</creatorcontrib><creatorcontrib>Luo, Yanhong</creatorcontrib><creatorcontrib>Dai, Ninan</creatorcontrib><creatorcontrib>Yang, Yan</creatorcontrib><creatorcontrib>He, Ying</creatorcontrib><creatorcontrib>Chen, Huajun</creatorcontrib><creatorcontrib>Zhao, Manlu</creatorcontrib><creatorcontrib>Fu, Xiaoyun</creatorcontrib><creatorcontrib>Chen, Tao</creatorcontrib><creatorcontrib>Xing, Zhouxiong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DAOJ: Directory of Open Access Journals</collection><jtitle>Frontiers in microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cai, Yulan</au><au>Luo, Yanhong</au><au>Dai, Ninan</au><au>Yang, Yan</au><au>He, Ying</au><au>Chen, Huajun</au><au>Zhao, Manlu</au><au>Fu, Xiaoyun</au><au>Chen, Tao</au><au>Xing, Zhouxiong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia</atitle><jtitle>Frontiers in microbiology</jtitle><addtitle>Front Microbiol</addtitle><date>2023-09-28</date><risdate>2023</risdate><volume>14</volume><spage>1197970</spage><epage>1197970</epage><pages>1197970-1197970</pages><issn>1664-302X</issn><eissn>1664-302X</eissn><abstract>Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an important role in host metabolism and immunity. Nevertheless, the effects of hyperoxia on gut microbiome and metabolome remain unclear, and metagenomic and metabolomics analysis were performed in this mouse study. C57BL/6 mice were randomly divided into a control (CON) group exposed to room air with fractional inspired oxygen (FiO ) of 21% and a hyperoxia (OXY) group exposed to FiO of 80% for 7 days, respectively. Fecal pellets were collected on day 7 and subjected to metagenomic sequencing. Another experiment with the same design was performed to explore the impact of hyperoxia on gut and serum metabolome. Fecal pellets and blood were collected and high-performance liquid chromatography with mass spectrometric analysis was carried out. At the phylum level, hyperoxia increased the ratio of ( = 0.049). At the species level, hyperoxia reduced the abundance of ( = 0.007), ( = 0.010), and ( = 0.011) . Linear discriminant analysis effect size (LEfSe) revealed that and , both belonging to , were the marker microbes of the CON group, while was the marker microbes of the OXY group. Metagenomic analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Carbohydrate-Active enZYmes (CAZy) revealed that hyperoxia provoked disturbances in carbohydrate and lipid metabolism. Fecal metabolomics analysis showed hyperoxia reduced 11-dehydro Thromboxane B2-d4 biosynthesis ( = 1.10 × 10 ). Hyperoxia blunted fecal linoleic acid metabolism ( = 0.008) and alpha-linolenic acid metabolism ( = 0.014). We showed that 1-docosanoyl-glycer-3-phosphate ( = 1.58 × 10 ) was the most significant differential serum metabolite inhibited by hyperoxia. In addition, hyperoxia suppressed serum hypoxia-inducible factor-1 (HIF-1, = 0.007) and glucagon signaling pathways ( = 0.007). Hyperoxia leads to gut dysbiosis by eliminating beneficial and oxygen strictly intolerant with genomic dysfunction of carbohydrate and lipid metabolism. In addition, hyperoxia suppresses unsaturated fatty acid metabolism in the gut and inhibits the HIF-1 and glucagon signaling pathways in the serum.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>37840730</pmid><doi>10.3389/fmicb.2023.1197970</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-302X
ispartof Frontiers in microbiology, 2023-09, Vol.14, p.1197970-1197970
issn 1664-302X
1664-302X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c756ac3f67ff4434b416254654654bcf
source Open Access: PubMed Central
subjects gut dysbiosis
gut metabolome
gut microbiome
hyperoxia
metagenomic sequencing
Microbiology
serum metabolome
title Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T12%3A08%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20metagenomic%20and%20metabolomics%20analysis%20of%20gut%20dysbiosis%20induced%20by%20hyperoxia&rft.jtitle=Frontiers%20in%20microbiology&rft.au=Cai,%20Yulan&rft.date=2023-09-28&rft.volume=14&rft.spage=1197970&rft.epage=1197970&rft.pages=1197970-1197970&rft.issn=1664-302X&rft.eissn=1664-302X&rft_id=info:doi/10.3389/fmicb.2023.1197970&rft_dat=%3Cproquest_doaj_%3E2878017369%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2878017369&rft_id=info:pmid/37840730&rfr_iscdi=true